Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits in the top decile of US sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count).

305 total trials 24 currently recruiting 252 completed early-phase tilt top decile by trial count

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): 305 sponsored US clinical trials, 24 recruiting.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sponsors 305 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 252 completed. 35 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pregnancy, with 8 trials.

Top-decile sponsor footprint

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ranks in the top decile of sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

252 of 279 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

305 total, page 2 of 7

COMPLETED Phase 1

Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome

NCT02153983

COMPLETED Phase 1

Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1

NCT02124083

TERMINATED

Fat Metabolism and Melanocortin 3 Receptors in African Americans

NCT01851421

COMPLETED Phase 1

Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children

NCT01888939

COMPLETED NA

Folic Acid and Zinc Supplementation Trial (FAZST)

NCT01857310

COMPLETED

Expansion of Childhood Relationship Study to Young Adult Romantic Relationships

NCT01866852

COMPLETED

Soft Tissue and Bone Development in Young Girls

NCT02654262

COMPLETED

Ovarian Stem Cells From Women With Ovarian Insufficiency

NCT01702935

COMPLETED

Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy

NCT01547767

COMPLETED

Brain-Derived Neurotrophic Factor in Obesity and Brain Function

NCT01517048

COMPLETED Phase 1

Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults

NCT01419535

COMPLETED

Noninvasive Study of Brain Connectivity With EEG and NIRS

NCT01493804

COMPLETED

Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning

NCT01468935

COMPLETED NA

Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging

NCT01212029

COMPLETED Phase 2

Mood and Insulin Resistance in Adolescents At-Risk for Diabetes

NCT01425905

TERMINATED Phase 1

Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children

NCT01237041

COMPLETED Phase 1

Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)

NCT01329016

COMPLETED

Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols

NCT01375543

COMPLETED

The NICHD Fetal Growth Study: Twin Gestations

NCT01369940

COMPLETED

Discussing Costs in the Doctor-Patient Encounter

NCT01503853

COMPLETED

Adrenal Hyperplasia Among Young People With PCOS

NCT01313455

COMPLETED Phase 4

Prevention of Iron Deficiency in Breastfed Infants

NCT01444261

COMPLETED

Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be

NCT01322529

TERMINATED

The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient Registry

NCT01187524

COMPLETED Phase 2

Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.

NCT01166425

COMPLETED NA

Randomized Trial of Home Versus Clinic-Based STD Testing

NCT01654991

TERMINATED

Studies of Autistic Patients: Gene Networks and Clinical Subtypes

NCT01092208

COMPLETED

Health Behavior in School-Age Children: NEXT Longitudinal Study 2009-2016

NCT01031160

COMPLETED

Exome Sequencing in Autistic Spectrum Disorder

NCT01059201

COMPLETED Phase 2

Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)

NCT00999375

COMPLETED Phase 1

Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine

NCT00975689

COMPLETED Phase 1

Cholesterol in ASD: Characterization and Treatment

NCT00965068

TERMINATED

Non-Invasive Non-Ionizing Polarized Imaging System to Assess Structure of Cervix

NCT00955864

COMPLETED Phase 1

Preventing Motor Vehicle Crashes Among Young Drivers: Evaluation of the Checkpoints Program Presented by the American Automobile Association

NCT00920049

COMPLETED

The National Standard for Normal Fetal Growth

NCT00912132

COMPLETED

National Children s Health Study

NCT00852904

COMPLETED

Global Study of Women's Health

NCT00849173

COMPLETED Phase 2

Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)

NCT00621816

COMPLETED NA

TDSM- Testosterone Dose Response in Surgically Menopausal Women

NCT00494208

COMPLETED

Health Behaviors in School-age Children: 2009-2010

NCT00797095

COMPLETED

Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil

NCT00853788

COMPLETED Phase 1

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

NCT00607542

COMPLETED

Epigenetics in the Aging Process

NCT00242255

COMPLETED

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

NCT00758108

COMPLETED Phase 4

Behavioral and Environmetal Factors and Time to Delivery

NCT00740506

COMPLETED Phase 1

Codeine in Mechanically Ventilated Neonates

NCT01322204

COMPLETED NA

Teenage Passenger Influences on Driving Performance of Teenage Drivers

NCT00716378

COMPLETED NA

Optimizing Social and Communication Outcomes for Toddlers With Autism

NCT00999778

TERMINATED

Establishment of Fibroid Tissue Bank

NCT00710346

COMPLETED

Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial

NCT00729144

← Previous Page 2 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 49
Phase 3 23
Phase 4 12

What is open in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline

24 recruiting of 305 indexed (8% open); 252 completed (83%).

Phase mix: 35 late (III/IV) vs 89 early (I/II) (early-phase heavy).

Top condition: Pregnancy (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): open-pipeline peers nationwide

Peers matched on 305 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 0%5%10%15% Total trials Recruiting share Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CelgeneAllerganKaiser PermanenteUniversity of ArkansasBoston Scientific CorporationNovo Nordisk A/SHoffmann-La RocheUnited Therapeutics
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 305 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

What to do with this Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) page

305 registered trials is a research-attention snapshot, not an endorsement of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) or any single study.

  • 24 of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pregnancy is the condition Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pregnancy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline card: 305 registered trials from official public datasets.Report a data error.